Waters Corporation (WAT) FY2026 YTD Q2 P&L / Income Statement

Waters Corporation (WAT) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-07-04. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total net revenues

2,912,000,000 US dollars

Cost of revenue (calculated)

1,590,000,000 US dollars

Gross profit (calculated)

1,322,000,000 US dollars

Operating expenses (calculated)

1,456,000,000 US dollars

Operating (loss) income

negative 134,000,000 US dollars

Other income (expense), net (calculated)

negative 95,000,000 US dollars

(Loss) income before income taxes

negative 229,000,000 US dollars

Benefit (provision) for income taxes

negative 21,000,000 US dollars

Net (loss) income

negative 208,000,000 US dollars

Waters Analytical & Material Sciences

1,442,000,000 US dollars

Waters Biosciences

600,000,000 US dollars

Waters Advanced Diagnostics

870,000,000 US dollars

Costs and operating expenses

1,590,000,000 US dollars

Restructuring charges

52,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Purchased intangibles amortization

396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Research and development expenses

218,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Selling and administrative expenses

788,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.